How does the USPTO determine if a biological material is “known and readily available”?
How does the USPTO determine if a biological material is “known and readily available”? The USPTO considers several factors to determine if a biological material is “known and readily available,” which may negate the need for a deposit. According to MPEP 2404: “The Office will accept commercial availability as evidence that a biological material is…
Read MoreHow can an applicant show that a biological material is known and readily available?
An applicant can demonstrate that a biological material is known and readily available through various means. According to MPEP 2404.01, some factors that may serve as evidence include: Commercial availability References to the biological material in printed publications Declarations of accessibility by those working in the field Evidence of predictable isolation techniques An existing deposit…
Read MoreHow does commercial availability affect plant patent prior art?
Commercial availability of plant materials can significantly impact what constitutes enabling prior art for plant patents. The MPEP 2121.03 provides an example in the case of Ex parte Thomson: “Seeds were commercially available more than 1 year prior to applicant’s filing date. One of ordinary skill in the art could grow the claimed cotton cultivar…
Read MoreWhat is the impact of commercial availability on biological material deposits for patents?
Commercial availability can significantly impact the need for biological material deposits in patent applications. According to MPEP 2404: “The USPTO will accept commercial availability as evidence that a biological material is known and readily available only when the evidence is clear and convincing that the public has access to the material.” However, commercial availability alone…
Read MoreHow does commercial availability affect the need for biological deposits?
Commercial availability of biological materials can significantly affect the need for making or replacing deposits in patent applications. According to MPEP 2407.03: “For example, a replacement deposit would not be required under the circumstances where access to the necessary biological material was established through commercial suppliers.” This statement indicates that if the biological material described…
Read MoreHow does commercial availability affect the determination of whether a biological material is known and readily available?
Commercial availability can be a factor in determining whether a biological material is known and readily available, but it’s not always sufficient on its own. According to MPEP 2404.01: “The Office will accept commercial availability as evidence that a biological material is known and readily available only when the evidence is clear and convincing that…
Read More